相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Vancomycin MIC creep in methicillin-resistant Staphylococcus aureus (MRSA) isolates from 2006 to 2010 in a hospital in China
W. Chang et al.
INDIAN JOURNAL OF MEDICAL MICROBIOLOGY (2015)
Slow VISA, a Novel Phenotype of Vancomycin Resistance, Found In Vitro in Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Strain Mu3
Michie Saito et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Evaluation of Vancomycin Population Susceptibility Analysis Profile as a Predictor of Outcomes for Patients with Infective Endocarditis Due to Methicillin-Resistant Staphylococcus aureus
Anthony M. Casapao et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
New epidemiology of Staphylococcus aureus infection in Asia
C-J Chen et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Is prediffusion test an alternative to improve accuracy in screening hVISA strains and to detect susceptibility to glycopeptides/lipopeptides?
Alessandro Conrado de Oliveira Silveira et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2014)
Antibiotic susceptibility survey of blood-borne MRSA isolates in Japan from 2008 through 2011
Hideaki Hanaki et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2014)
Glycopeptide intermediate Staphylococcus aureus and prevalence of the luk-PV gene in clinical isolates, in Northern Lebanon
M. -D. El Ayoubi et al.
MEDECINE ET MALADIES INFECTIEUSES (2014)
Emergence of methicillin-resistant, vancomycin-intermediate Staphylococcus aureus among patients associated with group A Streptococcal pharyngitis infection in southern India
Shanmugaraj Gowrishankar et al.
INFECTION GENETICS AND EVOLUTION (2013)
High vancomycin minimum inhibitory concentrations with heteroresistant vancomycin-intermediate Staphylococcus aureus in meticillin-resistant S. aureus bacteraemia patients
Jiun-Ling Wang et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
Carriage frequency, diversity and methicillin resistance of Staphylococcus aureus in Danish small ruminants
Jacob Eriksson et al.
VETERINARY MICROBIOLOGY (2013)
PREVALENCE OF HETEROGENEOUS GLYCOPEPTIDE INTERMEDIATE RESISTANCE IN METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS
Manu Chaudhary et al.
AMERICAN JOURNAL OF INFECTIOUS DISEASES (2013)
Low Prevalence of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates among Connecticut Veterans
Susan L. Fink et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
High Prevalence of Isolates with Reduced Glycopeptide Susceptibility in Persistent or Recurrent Bloodstream Infections Due to Methicillin-Resistant Staphylococcus aureus
Ilker Uckay et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Contribution of Selected Gene Mutations to Resistance in Clinical Isolates of Vancomycin-Intermediate Staphylococcus aureus
Cory Hafer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Daptomycin Versus Vancomycin for Bloodstream Infections Due to Methicillin-Resistant Staphylococcus aureus With a High Vancomycin Minimum Inhibitory Concentration: A Case-Control Study
Carol L. Moore et al.
CLINICAL INFECTIOUS DISEASES (2012)
Prevalence of isolates with reduced glycopeptide susceptibility in orthopedic device-related infections due to methicillin-resistant Staphylococcus aureus
P. Vaudaux et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2012)
An Outbreak of Heterogeneous Glycopeptide-Intermediate Staphylococcus aureus Related to a Device Source in an Intensive Care Unit
Sylvie Parer et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2012)
Current status of Glycopeptide intermediate and heterogenous Glycopeptide intermediate Staphylococcus aureus and their prevailing susceptibility pattern at two tertiary care hospitals of Pakistan
F. Kaleem et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2012)
Comparison of the clinical features, bacterial genotypes and outcomes of patients with bacteraemia due to heteroresistant vancomycin-intermediate Staphylococcus aureus and vancomycin-susceptible S. aureus
Ki-Ho Park et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Molecular epidemiology and clinical characteristics of hetero-resistant vancomycin intermediate Staphylococcus aureus bacteremia in a Taiwan Medical Center
Shang-Yi Lin et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2012)
MRSA epidemic linked to a quickly spreading colonization and virulence determinant
Min Li et al.
NATURE MEDICINE (2012)
Predicting Risk for Death from MRSA Bacteremia
Mina Pastagia et al.
EMERGING INFECTIOUS DISEASES (2012)
Systematic Review and Meta-Analysis of the Significance of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates
Sebastiaan J. van Hal et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
The incidence of heterogeneous vancomycin-intermediate Staphylococcus aureus correlated with increase of vancomycin MIC
Hongbin Chen et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2011)
Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia
Riad Khatib et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Vancomycin Susceptibility Trends and Prevalence of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus in Clinical Methicillin-Resistant S. aureus Isolates
Adam M. Pitz et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Detection of Staphylococcus aureus Isolates with Heterogeneous Intermediate-Level Resistance to Vancomycin in the United States
Sandra S. Richter et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Clinical characteristics of vancomycin minimum inhibitory concentration of 2 μg/ml methicillin-resistant Staphylococcus aureus strains isolated from patients with bacteremia
Yoshio Takesue et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2011)
Detection and Characterization of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates in Canada: Results from the Canadian Nosocomial Infection Surveillance Program, 1995-2006
Heather J. Adam et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Prevalence and accessory gene regulator (agr) analysis of vancomycin-intermediate Staphylococcus aureus among methicillin-resistant isolates in Taiwan-SMART program, 2003
C-M. Ho et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2010)
Clonal dissemination of meticillin-resistant and vancomycin-intermediate Staphylococcus aureus in a Taiwanese hospital
Po-Ren Hsueh et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Heteroresistance to glycopeptides in Italian meticillin-resistant Staphylococcus aureus (MRSA) isolates
Floriana Campanile et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Antibiotic Resistance: Gram-Positive (Poster Presentation)
B. Khanal et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2010)
Staphylococcus aureus with reduced glycopeptide susceptibility in Liverpool, UK
Andrew Kirby et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Vancomycin MIC creep in MRSA isolates from 1997 to 2008 in a healthcare region in Hong Kong
Pak-Leung Ho et al.
JOURNAL OF INFECTION (2010)
Detection of Heterogeneous Vancomycin Intermediate Staphylococcus aureus (hetero-VISA) in MRSA of Japanese Clinical Isolates
AMERICAN JOURNAL OF INFECTION CONTROL (2009)
Prevalence and Characterization of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates from 14 Cities in China
Wenjia Sun et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Prospective Comparison of the Clinical Impacts of Heterogeneous Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus (MRSA) and Vancomycin-Susceptible MRSA
K. C. Horne et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Clinical features and treatment outcomes of vancomycin-intermediate Staphylococcus aureus (VISA) and heteroresistant vancomycin-intermediate Staphylococcus aureus (hVISA) in a tertiary care institution in Singapore
R. K. C. Fong et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2009)
Occurrence of vancomycin-tolerant and heterogeneous vancomycin-intermediate strains (hVISA) among Staphylococcus aureus causing bloodstream infections in nine USA hospitals
Helio S. Sader et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Molecular and Phenotypic Characteristics of Methicillin-Resistant and Vancomycin-Intermediate Staphylococcus aureus Isolates from Patients with Septic Arthritis
Wei-Yao Wang et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
The First Vancomycin-Intermediate Staphylococcus aureus Strains Isolated from Patients in Thailand
Aroonlug Lulitanond et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Vancomycin MIC plus Heteroresistance and Outcome of Methicillin-Resistant Staphylococcus aureus Bacteremia: Trends over 11 Years
Adina C. Musta et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Clinical Features of Heteroresistant Vancomycin-Intermediate Staphylococcus aureus Bacteremia versus Those of Methicillin-Resistant S. aureus Bacteremia
Yasmin Maor et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
A re-evaluation of random-effects meta-analysis
Julian P. T. Higgins et al.
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY (2009)
Incidence and Characteristics of Vancomycin Nonsusceptible Strains of Methicillin-Resistant Staphylococcus aureus at Hershey Medical Center
Klaudia Kosowska-Shick et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Characterization of vancomycin-heteroresistant Staphylococcus aureus from the metropolitan area of Detroit, Michigan, over a 22-year period (1986 to 2007)
Michael J. Rybak et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Investigation of reduced susceptibility to glycopeptides among methicillin-resistant Staphylococcus aureus isolates from patients in Ireland and evaluation of agar screening methods for detection of heterogeneously glycopeptide-intermediate S-aureus
Margaret M. Fitzgibbon et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
Prevalence and charactenistics of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia in a tertiary care center
Yasmin Maor et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
Hetero-vancomycin-intermediate methicillin-resistant Staphylococcus aureus isolate from a medical center in Las Cruces, New Mexico
Alejandro Delgado et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
Community-associated methicillin-resistant Staphylococcus aureus isolates causing healthcare-associated infections
Cynthia L. Maree et al.
EMERGING INFECTIOUS DISEASES (2007)
Decreased susceptibility to glycopeptides in methicillin-resistant Staphylococcus aureus:: a 20 year study in a large French teaching hospital, 1983-2002
J Robert et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
In vitro exposure of community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains to vancomycin:: does vancomycin resistance occur?
SL Kleinschmidt et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)
Control and outcome of a large outbreak of colonization and infection with glycopeptide-intermediate Staphylococcus aureus in an intensive care unit
A de Lassence et al.
CLINICAL INFECTIOUS DISEASES (2006)
A 1 year surveillance study of glycopeptide-intermediate Staphylococcus aureus strains in a French hospital
F Garnier et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Comparison of genetic backgrounds of methicillin-resistant and -susceptible Staphylococcus aureus isolates from Portuguese hospitals and the community
MA de Sousa et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Methicillin-resistant Staphylococcus aureus heterogeneously resistant to vancomycin in a Turkish university hospital
B Sancak et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Low colonization prevalence of Staphylococcus aureus with reduced vancomycin susceptibility among patients undergoing hemodialysis in the San Francisco Bay area
JM Equía et al.
CLINICAL INFECTIOUS DISEASES (2005)
Investigation of Staphylococcus strains with heterogeneous resistance to glycopeptides in a Turkish university hospital
Y Nakipoglu et al.
BMC INFECTIOUS DISEASES (2005)
Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals
C Nonhoff et al.
CLINICAL MICROBIOLOGY AND INFECTION (2005)
Heterogeneous vancomycin-resistant Staphylococcus aureus (hetero-VISA) in Singapore
LH Sng et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2005)
Methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to glycopeptides (GISA) in 63 French general hospitals
GL Cartolano et al.
CLINICAL MICROBIOLOGY AND INFECTION (2004)
Emergence in Asian countries of Staphylococcus aureus with reduced susceptibility to vancomycin
JH Song et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Reference group choice and antibiotic resistance outcomes
KS Kaye et al.
EMERGING INFECTIOUS DISEASES (2004)
Screening for Staphylococcus aureus with a reduced susceptibility to vancomycin in:: a Belgian hospital
D Piérard et al.
PATHOLOGIE BIOLOGIE (2004)
Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection
TS Naimi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Prevalence, molecular epidemiology, and clinical significance of heterogeneous glycopeptide-intermediate Staphylococcus aureus in liver transplant recipients
F Bert et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Staphylococcus aureus with heterogeneous resistance to vancomycin:: Epidemiology, clinical significance, and critical assessment of diagnostic methods
C Liu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001
SK Fridkin et al.
CLINICAL INFECTIOUS DISEASES (2003)
Emergence of vancomycin-intermediate Staphylococcus aureus in a Belgian hospital:: microbiological and clinical features
O Denis et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
Quantifying heterogeneity in a meta-analysis
JPT Higgins et al.
STATISTICS IN MEDICINE (2002)
Vancomycin susceptibility of oxacillin-resistant Staphylococcus aureus isolates causing nosocomial bloodstream infections
SM Tallent et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2002)
Clonal spread of Staphylococcus aureus heterogeneously resistant to vancomycin in a university hospital in Korea
MN Kim et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2002)
Nationwide survey shows that methicillin-resistant Staphylococcus aureus strains heterogeneously and intermediately resistant to vancomycin are not disseminated throughout Japanese hospitals
Y Ike et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2001)
Incidence of Staphylococcus aureus with reduced susceptibility to glycopeptides in two French hospitals
ME Reverdy et al.
CLINICAL MICROBIOLOGY AND INFECTION (2001)
A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital
M Wootton et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus
FC Tenover et al.
EMERGING INFECTIOUS DISEASES (2001)
First report of methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Thailand
S Trakulsomboon et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2001)
Twenty months of screening for glycopeptide-intermediate Staphylococcus aureus
HM Aucken et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
A new class of genetic element, staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus
Y Katayama et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
分享论文
